Status:
RECRUITING
Spatially and Temporally Resolving Predictive Biomarkers of Postoperative Recurrence and Complications in Chronic Intestinal Inflammation
Lead Sponsor:
IRCCS Ospedale San Raffaele
Collaborating Sponsors:
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
Conditions:
Ulcerative Colitis
Crohn Disease
Eligibility:
All Genders
18-69 years
Brief Summary
A portion of patients with Inflammatory bowel disease often require surgical intervention since they do not respond to the current therapies. Besides this risk, patients may develop post-operative dis...
Detailed Description
A portion of patients with Inflammatory bowel disease often require surgical intervention since they do not respond to the current therapies. Besides this risk, patients may develop post-operative dis...
Eligibility Criteria
Inclusion
- adult (age \>18 years) patients with histologically confirmed CD or UC undergoing intestinal resection due to stricturing disease, regardless of their current or past medical treatment;
- given that it is an observational study, also pregnant and breastfeeding patients could be included;
- able and willing to sign the informed consent.
Exclusion
- patients \<18 years or \> 70 years;
- patients with unconfirmed both UC and CD diagnoses;
- patients with superimposed dysplasia or cancer diagnosis and resections for which post- operative endoscopic assessment of recurrence is not feasible;
- patients unable or unwilling to sign the informed consent.
Key Trial Info
Start Date :
February 27 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06516341
Start Date
February 27 2025
End Date
September 1 2026
Last Update
March 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale San Raffaele
Milan, Italy, Italy, 20132